Aptinyx discovering and developing innovative therapies for challenging disorders of the brain and nervous system

Challenging disorders of the brain. Our proprietary compounds modulate. Involved in nerve cell. We seek to leverage our experience. Track record of success to rapidly advance. Development for patients in need. November 14, 2016. Aptinyx to Present Data for NYX-2925 in Models of Neuropathic Pain and Traumatic Brain Injury at Neuroscience 2016. November 10, 2016. September 13, 2016. July 13, 2016. Aptinyx Initiates Dosing in Phase 1 Clinical Study of Lead NMDA-Receptor Modulator, NYX-2925.

OVERVIEW

This web site aptinyx.com currently has an average traffic classification of zero (the smaller the more users). We have probed seven pages inside the site aptinyx.com and found nine websites linking to aptinyx.com.
Pages Analyzed
7
Links to this site
9

APTINYX.COM RANKINGS

This web site aptinyx.com has seen alternating amounts of traffic for the duration of the year.
Traffic for aptinyx.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for aptinyx.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for aptinyx.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB PAGE

Longitude Capital Venture Growth Investing in Life Sciences

We invest in both privately held and publicly traded life science companies through a variety of investment approaches. 2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multi.

WHAT DOES APTINYX.COM LOOK LIKE?

Desktop Screenshot of aptinyx.com Mobile Screenshot of aptinyx.com Tablet Screenshot of aptinyx.com

APTINYX.COM HOST

Our web crawlers discovered that a single root page on aptinyx.com took three thousand and sixty-two milliseconds to download. Our web crawlers could not find a SSL certificate, so I consider aptinyx.com not secure.
Load time
3.062 seconds
SSL
NOT SECURE
Internet Address
216.92.23.164

WEBSITE IMAGE

SERVER OPERATING SYSTEM AND ENCODING

I found that this website is using the Apache/2.2.31 os.

PAGE TITLE

Aptinyx discovering and developing innovative therapies for challenging disorders of the brain and nervous system

DESCRIPTION

Challenging disorders of the brain. Our proprietary compounds modulate. Involved in nerve cell. We seek to leverage our experience. Track record of success to rapidly advance. Development for patients in need. November 14, 2016. Aptinyx to Present Data for NYX-2925 in Models of Neuropathic Pain and Traumatic Brain Injury at Neuroscience 2016. November 10, 2016. September 13, 2016. July 13, 2016. Aptinyx Initiates Dosing in Phase 1 Clinical Study of Lead NMDA-Receptor Modulator, NYX-2925.

CONTENT

This web site aptinyx.com has the following in the homepage, "We seek to leverage our experience." Our analyzers saw that the website also stated " Track record of success to rapidly advance." The Website also said " Development for patients in need. Aptinyx to Present Data for NYX-2925 in Models of Neuropathic Pain and Traumatic Brain Injury at Neuroscience 2016. Aptinyx Initiates Dosing in Phase 1 Clinical Study of Lead NMDA-Receptor Modulator, NYX-2925."

VIEW SIMILAR WEBSITES

Yrshas Blogg Teenagers think about Yrsha every 15 seconds. Good luck concentrating.

Teenagers think about Yrsha every 15 seconds. Så undviker du bäst en iller. Livsviktigt ifall du skulle stöta på en iller. Eller var det bussen? Det var inte så noga, den har en motor i alla fall. Om det inte var en cykel, för då har den ingen motor. Skulle inte bilen komma snart? Eller var det bussen? Cykel Eller, vem skulle hämta dig med en cykel? .

長生緣 - 長生學 - 人電學 - 能量醫學

長生緣 - 長生學 - 人電學 - 能量醫學.

AchermanLaw

PROBATE, AND VARIOUS ESTATE PLANNING INSTRUMENTS. Create a free website or blog at WordPress.

Broadbent Taylor, Attorneys at Law 160 Doyle Road Holden MA 01520 508438-1198 www.kbctlaw.com Providing quality legal representation throughout Massachusetts

Broadbent and Taylor, Attorneys at Law. On December 23, 2016, USCIS raised the fees to file for naturalization, a green card, and more.